{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:39Z","timestamp":1792801479594,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.neuroscience.2011.08.010","type":"journal-article","created":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T06:16:12Z","timestamp":1312784172000},"page":"189-194","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"194","author":[{"given":"S.K.","family":"Kidd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2011.08.010_bib1","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1111\/j.1460-9568.2006.05192.x","article-title":"Neuroprotection in Parkinson models varies with toxin administration protocol","volume":"24","author":"Anderson","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1460-9568.2008.06356.x","article-title":"Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced pParkinsonism","volume":"28","author":"Anderson","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib3","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","article-title":"Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice","volume":"71","author":"Aubin","year":"1998","journal-title":"J Neurochem"},{"issue":"Suppl 3","key":"10.1016\/j.neuroscience.2011.08.010_bib4","first-page":"3","article-title":"History of the development of valproate for treatment of bipolar disorder","volume":"56","author":"Bowden","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1096\/fj.04-1551fje","article-title":"Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death","volume":"18","author":"Chen","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","article-title":"Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes","volume":"11","author":"Chen","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2007.06.053","article-title":"Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity","volume":"149","author":"Chen","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bcp.2008.04.010","article-title":"GSK3beta and endoplasmic reticulum stress mediate rotenone-induced death of SK-\u2013N-MC neuroblastoma cells","volume":"76","author":"Chen","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib9","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","article-title":"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease","volume":"98","author":"Du","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib10","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1124\/mol.106.027912","article-title":"Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain","volume":"70","author":"Faraco","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s002109900079","article-title":"Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice","volume":"360","author":"Ferger","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib12","first-page":"645","article-title":"Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers","volume":"31","author":"Fisar","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02259133","article-title":"Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis","volume":"88","author":"Fuxe","year":"1992","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(02)00299-1","article-title":"Lithium and valproic acid: parallels and contrasts in diverse signaling contexts","volume":"96","author":"Gurvich","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","article-title":"The role of glial reaction and inflammation in Parkinson's disease","volume":"991","author":"Hirsch","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 3","key":"10.1016\/j.neuroscience.2011.08.010_bib16","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s002210000370","article-title":"Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset","volume":"133","author":"Jenner","year":"2000","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpsychires.2010.05.011","article-title":"Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania","volume":"45","author":"Jornada","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.brainres.2010.07.041","article-title":"Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition","volume":"1354","author":"Kidd","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","article-title":"Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action","volume":"321","author":"Kim","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0197-0186(90)90109-7","article-title":"Functional alterations in striatal cholinergic and striato-nigral gabaergic neurons following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration","volume":"16","author":"Kuriyama","year":"1990","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1203\/PDR.0b013e31806790d7","article-title":"Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice","volume":"62","author":"Lagrue","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib23","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1212\/WNL.47.6_Suppl_3.153S","article-title":"The etiology of Parkinson's disease with emphasis on the MPTP story","volume":"47","author":"Langston","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib24","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1523\/JNEUROSCI.5467-07.2008","article-title":"Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition","volume":"28","author":"Leng","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2010.04.013","article-title":"Potent neuroprotective effects of novel structural derivatives of valproic acid: potential roles of HDAC inhibition and HSP70 induction","volume":"476","author":"Leng","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0006-8993(89)91044-5","article-title":"Valproate enhances GABA turnover in the substantia nigra","volume":"501","author":"L\u00f6scher","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"L\u00f6scher","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2011.03.040","article-title":"Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition","volume":"1396","author":"Lv","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib29","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1471-4159.2009.06385.x","article-title":"Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation","volume":"111","author":"Marinova","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(86)90773-9","article-title":"Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice","volume":"128","author":"Melamed","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(00)02189-2","article-title":"Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"864","author":"Mohanakumar","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.10.021","article-title":"Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia","volume":"134","author":"Peng","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2005.09.013","article-title":"Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Petri","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib34","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib35","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.1139-07.2007","article-title":"Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model","volume":"27","author":"Rouaux","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib36","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.0737363100","article-title":"Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway","volume":"100","author":"Ryu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib37","doi-asserted-by":"crossref","first-page":"39962","DOI":"10.1074\/jbc.M505524200","article-title":"Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice","volume":"280","author":"Shen","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1987.tb03384.x","article-title":"Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"49","author":"Singer","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0892-0362(02)00222-2","article-title":"MPTP: insights into parkinsonian neurodegeneration","volume":"24","author":"Speciale","year":"2002","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1471-4159.2003.02004.x","article-title":"Regulation of microglial inflammatory response by histone deacetylase inhibitors","volume":"87","author":"Suuronen","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib42","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.neuropharm.2007.03.017","article-title":"Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity","volume":"52","author":"Wang","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2011.08.010_bib43","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221100933X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221100933X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T18:14:24Z","timestamp":1560449664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645221100933X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":43,"alternative-id":["S030645221100933X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2011.08.010","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}